KRAS and exocrine pancreatic carcinoma: In contrast, the binding of Gal-8 to farnesylated K-Ras4B inhibits Ras activation because siRNA-mediated depletion of Gal-8 increases K-Ras4B content and ERK1/2 activity in lung and pancreatic carcinoma cells [23].